# Amgen

> Amgen is a biotechnology company that discovers, develops, manufactures and delivers human
> therapeutics. Founded in 1980, it uses living cells to make biologic medicines for
> cardiovascular and metabolic disease, oncology, inflammation, rare disease, bone health and
> obesity, and markets biosimilars, operating in approximately 100 countries.

## Machine-readable surface: none

Amgen publishes **no public API**. As of 2026-09-02 there is no developer portal, no API
reference, no OpenAPI/AsyncAPI/GraphQL/WSDL/gRPC contract, no MCP server and no A2A agent card
on any Amgen-operated host. Its 2,773-URL corporate sitemap contains no developer or API
section. `www.amgen.com/openapi.json` and `www.amgen.com/llms.txt` return 404; the entire
`/.well-known/` directory returns 403 from the edge. `api.amgen.com` resolves but is a shared
Salesforce Commerce Cloud edge serving an unrelated tenant, not an Amgen API host.

This file is generated by API Evangelist from the public record. It is not published by Amgen.

## Company

- [Amgen](https://www.amgen.com): Corporate site — pipeline, therapy areas, products, science.
- [About Amgen](https://www.amgen.com/about): History, mission, leadership, therapy areas.
- [How We Operate](https://www.amgen.com/about/how-we-operate): Corporate governance, business
  ethics and compliance, policies, practices and disclosures.
- [Contact Us](https://www.amgen.com/contact-us): Locations, product inquiries, feedback.

## Science and R&D

- [Research and Development Strategy](https://www.amgen.com/science/research-and-development-strategy):
  Human and disease biology, novel targets and modalities, clinical trial optimization.
- [AI in Research and Development](https://www.amgen.com/science/research-and-development-strategy/ai-in-research-and-development):
  Amgen's use of generative biology and AI in discovery and clinical development.
- [Clinical Trials](https://www.amgen.com/science/clinical-trials): Trial participation,
  information for healthcare professionals, out-of-hours support.
- [Clinical Trial Transparency, Data Sharing and Disclosure Practices](https://www.amgen.com/science/clinical-trials/clinical-data-transparency-practices):
  How Amgen shares clinical trial data with external researchers — a request-based, human
  process, not an API.
- [Biosimilars](https://www.amgen.com/science/biosimilars): Development and regulatory pathways.

## Partners

- [Partners](https://www.amgen.com/partners): Academic collaborations, wholesalers, suppliers.
- [Academic Collaborations](https://www.amgen.com/partners/academic-collaborations): New
  requests, refills and amendments, scientific reports and notices of invention.
- [Suppliers](https://www.amgen.com/partners/suppliers): Procurement guidelines, code of
  conduct, invoice guidelines, shipping and receiving, onboarding, terms and conditions.

## Open source

- [Amgen on GitHub](https://github.com/Amgen): Two public repositories.
- [GUMPS](https://github.com/Amgen/GUMPS): Generic Universal Modeling Platform Software —
  Amgen's BSD-3-Clause Python library for chaining computational models and regressors.
  Version 3.1.3; source distribution only, not published to PyPI; last push 2024-05-30.

## Security, privacy and legal

- [Cybersecurity and Data Privacy](https://www.amgen.com/responsibility/a-healthy-amgen/cybersecurity-and-data-privacy):
  Governance of Amgen's information security and privacy programs. Names no certification,
  no bug bounty and no vulnerability disclosure contact.
- [Privacy Statement](https://www.amgen.com/privacy-statement)
- [Health Data Privacy Policy](https://www.amgen.com/healthdataprivacypolicy)
- [Terms of Use](https://www.amgen.com/terms-of-use)

## Newsroom and stories

- [Newsroom](https://www.amgen.com/newsroom): Press releases and company statements.
- [Stories](https://www.amgen.com/stories): Long-form company and science storytelling.

## Optional

- [API Evangelist profile](https://providers.apis.io/providers/amgen/): The catalog record
  this file was generated from, including the probe evidence behind the "no API" finding.